GALANDRA, CATERINA
 Distribuzione geografica
Continente #
EU - Europa 86
AS - Asia 75
NA - Nord America 72
SA - Sud America 13
AF - Africa 11
Totale 257
Nazione #
US - Stati Uniti d'America 64
IT - Italia 35
SG - Singapore 26
CN - Cina 18
RU - Federazione Russa 18
DE - Germania 11
HK - Hong Kong 11
VN - Vietnam 9
BR - Brasile 8
ZA - Sudafrica 7
FR - Francia 6
GB - Regno Unito 4
MX - Messico 4
MA - Marocco 3
BD - Bangladesh 2
CA - Canada 2
EC - Ecuador 2
ES - Italia 2
FI - Finlandia 2
IN - India 2
PL - Polonia 2
TR - Turchia 2
BE - Belgio 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
KZ - Kazakistan 1
LT - Lituania 1
NL - Olanda 1
PY - Paraguay 1
SI - Slovenia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 257
Città #
San Jose 17
Singapore 15
Rome 12
Hong Kong 10
Ashburn 8
Beijing 7
Milan 6
Ho Chi Minh City 5
Johannesburg 5
Los Angeles 5
Lauterbourg 4
Moscow 4
Munich 4
Boardman 3
Dallas 3
Redondo Beach 3
Casablanca 2
Dhaka 2
Frankfurt am Main 2
Hanoi 2
Naples 2
Nuremberg 2
Orem 2
Osio Sotto 2
Querétaro 2
Quito 2
Santa Clara 2
Treviso 2
Turin 2
Turku 2
Warsaw 2
Almaty 1
Amman 1
Ankara 1
Asunción 1
Atlanta 1
Baoding 1
Belo Horizonte 1
Biên Hòa 1
Bonito 1
Brno 1
Cairo 1
Cape Town 1
Changzhou 1
Cochabamba 1
Council Bluffs 1
Düsseldorf 1
El Jadida 1
Elk Grove Village 1
Estrela dOeste 1
Florence 1
Guangzhou 1
Guiyang 1
Haikou 1
Iguape 1
Istanbul 1
Itaquaquecetuba 1
Jakarta 1
Kowloon City 1
Las Vegas 1
Liège 1
Ljubljana 1
Ludhiana 1
Madrid 1
Magenta 1
Manchester 1
Mexico City 1
Milwaukee 1
Montreal 1
Nagpur 1
Natal 1
Palotina 1
Parma 1
Pavia 1
Piscataway 1
Pretoria 1
Santo Domingo 1
Schaumburg 1
Tashkent 1
Tegucigalpa 1
Thanh Mỹ Tây 1
Tokyo 1
Toronto 1
Valencia 1
Volta Redonda 1
Xinxiang 1
Zagreb 1
Totale 197
Nome #
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 101
Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects 62
Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) 56
Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global Scale 43
Totale 262
Categoria #
all - tutte 981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202422 0 0 0 0 0 4 6 4 0 3 2 3
2024/202597 6 2 1 0 1 9 14 4 27 7 8 18
2025/2026143 13 4 23 17 21 5 30 6 15 9 0 0
Totale 262